WASHINGTON (MedPage Today) — Countries such as Sweden, the Netherlands, New Zealand, the United Kingdom and Norway have nearly universal adoption of health information technology (HIT) while the United States lags painfully behind.
No Comments »
Filed under: General Health News
After two reports of moldy or musty odors emanating from Lipitor ((atorvastatin calcium) 40 milligram tablet bottles, Pfizer has issued a recall of a further 38,000 bottles. Two weeks ago the company had recalled 190,000 bottles for the same reason. Lipitor is a cholesterol-lowering medication; it also stabilizes plaque and prevents strokes. Lipitor is a [...]
No Comments »
Filed under: Pharmacy News
A new study by University of North Carolina at Chapel Hill and Norwegian researchers has found that women with anorexia nervosa are much more likely to have both unplanned pregnancies and induced abortions than women who don’t have the serious eating disorder…
No Comments »
Filed under: Women's Health
WASHINGTON (MedPage Today) — It was a bleak week for those who are banking on the success of diet drugs: The FDA informed two separate pharmaceutical companies that the agency cannot approve the companies’ weight-loss pills.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — Contamination with oversulfated chondroitin sulfate — the same contaminant responsible for a worldwide heparin recall in 2008 — has prompted a new recall by B. Braun Medical.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — Federal officials said they’ve used a new chemical test to confirm what earlier tests have found — Gulf seafood is safe to eat.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has approved the novel, atypical antipsychotic lurasidone (Latuda) for the treatment of adult schizophrenia.
No Comments »
Filed under: General Health News
(MedPage Today) — Europe’s equivalent of the FDA has advised that patients with Fabry disease receive the full label-recommended dosage of Genzyme’s agalsidase-beta (Fabrazyme) despite the ongoing shortage of the drug, which is one of two enzyme replacement products available to treat the genetic disease.
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — The FDA has approved the novel, atypical antipsychotic lurasidone (Latuda) for the treatment of adult schizophrenia.
No Comments »
Filed under: Pharmacy News
OptiNose Inc. announced the results from an analysis comparing the Phase II clinical trial obtained with its novel delivery technology to that of other formulations. The analysis suggests rapid absorption rate alone may not explain the efficacy in migraines treated with sumatriptan delivered with the Company’s novel bi-directional technology. The results will be presented at [...]
No Comments »
Filed under: Pharmacy News
